Clinical trial

Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer

NCT00687648

Study summary

ClinicalTrials.gov

Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

6 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record anastrozole Normalized identity: anastrozole View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record cyclophosphamide Normalized identity: cyclophosphamide View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record exemestane Normalized identity: exemestane View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record letrozole Normalized identity: letrozole View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record methotrexate Normalized identity: methotrexate View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record prednisolone Normalized identity: prednisolone View linked drug · Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2008-05-01

PhasePHASE2

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

anastrozoleDRUG · verified · RxNorm: anastrozole

cyclophosphamideDRUG · verified · RxNorm: cyclophosphamide

exemestaneDRUG · verified · RxNorm: exemestane

letrozoleDRUG · verified · RxNorm: letrozole

methotrexateDRUG · verified · RxNorm: methotrexate

prednisoloneDRUG · verified · RxNorm: prednisolone

Sponsors & collaborators

National Cancer Centre, Singaporelead sponsor

Mapped research locations

SingaporeSingapore1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00687648 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.